Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucrase for Functional Sucrase Deficiency in Short Bowel Syndrome
NCT04604275Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Jan 2022
- Primary completion
- Sep 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sacrosidase in short bowel syndrome (SBS), sponsored by University of Miami. Started Jan 2022; status: terminated.
02
Drugs
sacrosidase
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT04604275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04604275.